| # | Drug | Count |
|---|---|---|
| 0 | ARIPIPRAZOLE | 4 |
| 1 | ARIPIPRAZOLE ORAL | 3 |
| 2 | ARIPIPRAZOLE ORALLY DISINTEGRATING | 3 |
| 3 | ASPIRIN | 3 |
| 4 | ASPIRIN 325 MG | 3 |
| 5 | ASPIRIN 81 MG | 3 |
| 6 | GABAPENTIN | 3 |
| 7 | NICOTINE | 3 |
| 8 | NICOTINE POLACRILEX | 3 |
| 9 | NICOTINE POLACRILEX MINI | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SODIUM FLUORIDE1.1%, POTASSIUM NITRATE 5% | 1 | 0.5000 |
| 1 | LISDEXAMFETAMINE DIMESYLATE CAPSULES | 1 | 0.0002 |
| 2 | BETAMETHASONE DIPROPIONATE | 1 | 0.0001 |
| 3 | TESTOSTERONE CYPIONATE | 1 | 0.0001 |
| 4 | OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN | 1 | 0.0001 |
| 5 | VALBENAZINE | 2 | 0.0001 |
| 6 | NICOTINE POLACRILEX | 3 | 0.0001 |
| 7 | NICOTINE | 3 | 0.0001 |
| 8 | ROMOSOZUMAB-AQQG | 1 | 0.0001 |
| 9 | ERGOCALCIFEROL | 2 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |
| 1 | Non-narcotic Antitussive [EPC] | 1 | 0.0001 |
| 2 | Cholinergic Nicotinic Agonist [EPC] | 3 | 0.0000 |
| 3 | Leukotriene Receptor Antagonist [EPC] | 1 | 0.0000 |
| 4 | Peroxisome Proliferator Receptor alpha Agonist [EPC] | 1 | 0.0000 |
| 5 | 5-alpha Reductase Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Interleukin-23 Antagonist [EPC] | 1 | 0.0000 |
| 7 | Atypical Antipsychotic [EPC] | 4 | 0.0000 |
| 8 | Aromatase Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Aldosterone Antagonist [EPC] | 1 | 0.0000 |